Figure 2From: Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regimens improves fasting lipid profiles, maintains virologic suppression, and simplifies treatmentLeast squares mean change from baseline in fasting serum total cholesterol.Back to article page